Search Results - "Charytan, David M"

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series by Rapkiewicz, Amy V., Mai, Xingchen, Carsons, Steven E., Pittaluga, Stefania, Kleiner, David E., Berger, Jeffrey S., Thomas, Sarun, Adler, Nicole M., Charytan, David M., Gasmi, Billel, Hochman, Judith S., Reynolds, Harmony R.

“…There is increasing recognition of a prothrombotic state in COVID-19. Post-mortem examination can provide important mechanistic insights. We present a COVID-19…”
Get full text

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial by Charytan, David M, Sabatine, Marc S, Pedersen, Terje R, Im, KyungAh, Park, Jeong-Gun, Pineda, Armando Lira, Wasserman, Scott M, Deedwania, Prakash, Olsson, Anders G, Sever, Peter S, Keech, Anthony C, Giugliano, Robert P

“…Data on PCSK9 inhibition in chronic kidney disease (CKD) is limited. The purpose of this study was to compare outcomes with evolocumab and placebo according to…”
Get full text

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial by Jardine, Meg J, Zhou, Zien, Mahaffey, Kenneth W, Oshima, Megumi, Agarwal, Rajiv, Bakris, George, Bajaj, Harpreet S, Bull, Scott, Cannon, Christopher P, Charytan, David M, de Zeeuw, Dick, Di Tanna, Gian Luca, Greene, Tom, Heerspink, Hiddo J L, Levin, Adeera, Neal, Bruce, Pollock, Carol, Qiu, Rose, Sun, Tao, Wheeler, David C, Zhang, Hong, Zinman, Bernard, Rosenthal, Norman, Perkovic, Vlado

“…Canagliflozin reduced renal and cardiovascular events in people with type 2 diabetes in the CREDENCE trial. We assessed efficacy and safety of canagliflozin by…”
Get full text

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) by Herzog, Charles A., Asinger, Richard W., Berger, Alan K., Charytan, David M., Díez, Javier, Hart, Robert G., Eckardt, Kai-Uwe, Kasiske, Bertram L., McCullough, Peter A., Passman, Rod S., DeLoach, Stephanie S., Pun, Patrick H., Ritz, Eberhard

“…Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high, and the presence of CKD worsens outcomes of cardiovascular…”
Get full text

Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage by Charytan, David M, Skali, Hicham, Shah, Nishant R, Veeranna, Vikas, Cheezum, Michael K, Taqueti, Viviany R, Kato, Takashi, Bibbo, Courtney R, Hainer, Jon, Dorbala, Sharmila, Blankstein, Ron, Di Carli, Marcelo F

“…Microvascular rarefaction is found in experimental uremia, but data from patients with chronic kidney disease (CKD) are limited. We therefore quantified…”
Get more information

Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial by Heerspink, Hiddo J.L., Oshima, Megumi, Zhang, Hong, Li, Jingwei, Agarwal, Rajiv, Capuano, George, Charytan, David M., Craig, Jagriti, de Zeeuw, Dick, Di Tanna, Gian Luca, Levin, Adeera, Neal, Bruce, Perkovic, Vlado, Wheeler, David C., Yavin, Yshai, Jardine, Meg J.

“…Canagliflozin reduced the risk of kidney failure and related outcomes in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) in the…”
Get full text

Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States by Charytan, David M., MD, MSc, Patrick, Amanda R., MSc, Liu, Jun, MD, Setoguchi, Soko, MD, DrPH, Herzog, Charles A., MD, Brookhart, M. Alan, PhD, Winkelmayer, Wolfgang C., MD, ScD

“…Background Sudden cardiac death constitutes the leading cause of death in patients receiving dialysis. Little is known about the trends in implantable…”
Get full text

Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia by Charytan, David M., MD, MSc, Fishbane, Steven, MD, Malyszko, Jolanta, MD, FERA, McCullough, Peter A., MD, MPH, Goldsmith, David, MA, MB, BChir, FRCP, FERA

“…The association between chronic kidney disease (CKD) and cardiovascular disease (CVD) is well established, and there is mounting evidence of interorgan cross…”
Get full text

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy by MOSLEHI, Javid, MINAMISHIMA, Yoji Andrew, JIANRU SHI, NEUBERG, Donna, CHARYTAN, David M, PADERA, Robert F, SIGNORETTI, Sabina, LIAO, Ronglih, KAELIN, William G

“…Ischemic cardiomyopathy is the major cause of heart failure and a significant cause of morbidity and mortality. The degree of left ventricular dysfunction in…”
Get full text

Spironolactone in Dialysis: What’s Old Is New Again by Charytan, David M., MD, MSc

Get full text

Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City by Charytan, David M., Parnia, Sam, Khatri, Minesh, Petrilli, Christopher M., Jones, Simon, Benstein, Judith, Horwitz, Leora I.

“…Reports from the United States suggest that acute kidney injury (AKI) frequently complicates coronavirus disease 2019 (COVID-19), but understanding of AKI…”
Get full text

Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function by Mavrakanas, Thomas A., Khattak, Aisha, Wang, Wei, Singh, Karandeep, Charytan, David M.

“…Abstract Background/Aims: Chronic kidney disease (CKD) is common among patients with heart failure with preserved ejection fraction (HFpEF) and is associated…”
Get full text

The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials by Kang, Amy, Smyth, Brendan, Neuen, Brendon L., Heerspink, Hiddo J. L., Di Tanna, Gian Luca, Zhang, Hong, Arnott, Clare, Hockham, Carinna, Agarwal, Rajiv, Bakris, George, Charytan, David M., Zeeuw, Dick, Greene, Tom, Levin, Adeera, Pollock, Carol, Wheeler, David C., Mahaffey, Kenneth W., Perkovic, Vlado, Jardine, Meg J.

“…Aims To assess whether the sodium‐glucose cotransporter‐2 (SGLT2) inhibitor canagliflozin affects risk of non‐genital skin and soft tissue infections (SSTIs)…”
Get full text

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD by Mavrakanas, Thomas A, Khattak, Aisha, Singh, Karandeep, Charytan, David M

“…Echocardiographic characteristics across the spectrum of chronic kidney disease (CKD) have not been well described. We assessed the echocardiographic…”
Get full text

Coronary Vascular Dysfunction and Prognosis in Patients With Chronic Kidney Disease by Murthy, Venkatesh L., MD, PhD, Naya, Masanao, MD, PhD, Foster, Courtney R., BS, Hainer, Jon, BS, Gaber, Mariya, ALM, Dorbala, Sharmila, MD, MPH, Charytan, David M., MD, MSc, Blankstein, Ron, MD, Di Carli, Marcelo F., MD

“…Objectives This study sought to evaluate whether impaired vasodilator function, an early manifestation of coronary artery disease, which precedes angiographic…”
Get full text

Cost-Effectiveness of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease and Acute Coronary Syndromes in the US Medicare Program by Reynolds, Matthew R, Gong, Tingting, Li, Shuling, Herzog, Charles A, Charytan, David M

“…Background Coronary revascularization provides important long-term clinical benefits to patients with high-risk presentations of coronary artery disease,…”
Get full text

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials by Mavrakanas, Thomas A, Aurian-Blajeni, D Ezra, Charytan, David M

“…The optimal timing of renal replacement therapy (RRT) initiation in acute kidney injury (AKI) remains a matter of debate. A systematic review and meta-analysis…”
Get full text

Early Angiography in Patients with Chronic Kidney Disease: A Collaborative Systematic Review by Charytan, David M, Wallentin, Lars, Lagerqvist, Bo, Spacek, Rudolf, De Winter, Robbert J, Stern, Noam M, Braunwald, Eugene, Cannon, Christopher P, Choudhry, Niteesh K

“…In the general population, an early invasive strategy of routine coronary angiography is superior to a conservative strategy of selective angiography in…”
Get full text

Myocardial Cytoskeletal Adaptations in Advanced Kidney Disease by Halim, Arvin, Narayanan, Gayatri, Hato, Takashi, Ho, Lilun, Wan, Douglas, Siedlecki, Andrew M, Rhee, Eugene P, Allegretti, Andrew S, Nigwekar, Sagar U, Zehnder, Daniel, Hiemstra, Thomas F, Bonventre, Joseph V, Charytan, David M, Kalim, Sahir, Thadhani, Ravi, Lu, Tzongshi, Lim, Kenneth

“…Background The myocardial cytoskeleton functions as the fundamental framework critical for organelle function, bioenergetics and myocardial remodeling. To…”
Get full text

Conservative Kidney Management Practice Patterns and Resources in the United States: A Cross-Sectional Analysis of CKDopps (Chronic Kidney Disease Outcomes and Practice Patterns Study) Data by Scherer, Jennifer S., Bieber, Brian, de Pinho, Natalia Alencar, Masud, Tahsin, Robinson, Bruce, Pecoits-Filho, Roberto, Schiedell, Joy, Goldfeld, Keith, Chodosh, Joshua, Charytan, David M.

“…Conservative kidney management (CKM) is a viable treatment option for many patients with chronic kidney disease. However, CKM practices and resources in the…”
Get full text